ClinicalTrials.Veeva

Menu

Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study

T

The Christie NHS Foundation Trust

Status

Completed

Conditions

Hodgkin Lymphoma

Study type

Observational

Funder types

Other

Identifiers

NCT04396119
CFTSp178
276443 (Other Identifier)

Details and patient eligibility

About

To explore the topic of lung cancer screening following treatment for Hodgkin lymphoma from the perspective of survivors

Full description

Explore survivors' attitudes towards lung cancer and lung cancer screening Explore survivors' understanding of cancer screening as a concept and the benefits of screening and early detection Explore survivors' level of awareness of and attitudes towards their lung cancer risk Explore survivors' views on the barriers and motivating factors that would impact their decision to attend a lung cancer screening test

Enrollment

30 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Details held in the ADAPT database at The Christie NHS Foundation trust
  • Responded to most recent ADAPT study questionnaire (April - August 2019)
  • Aged 18-80
  • Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years
  • Able to provide informed consent
  • Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or alkylating agent containing chemotherapy.

Exclusion criteria

  • Previous or current diagnosis of lung cancer
  • Stated within 2019 health questionnaire that they did not wish to be contacted
  • Have participated in lung cancer screening through the Manchester Lung Health Checks

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems